CSL Plasma Inc. is one of the world's largest collectors of human plasma.
As a leader in plasma collection, CSL Plasma is committed to excellence and innovation in everything we do. Our work helps to ensure that tens of thousands of people are able to live normal, healthy lives. We are committed to our work because lives depend on us.
CSL Plasma, headquartered in Boca Raton, FL, is a division of CSL Behring, a plasma protein biotherapies company headquartered in King of Prussia, Pennsylvania.
CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufactures and markets a range of plasma-derived and recombinant therapies worldwide.
CSL therapies are used to treat coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. The company’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn. For more information, visit www.cslbehring.com.
CSL Behring is a member of the CSL Group of companies. The parent company, CSL Limited (ASX:CSL), is headquartered in Melbourne, Australia. For more information, visit www.csl.com.au.
At CSL Plasma, we strive to act with the utmost integrity in everything we do. Our high standards guide us as we work with our donors, ensure the quality of the plasma we collect, and manage our valued employees.
You are accessing a Web site maintained by a third party over whom CSL Behring has no control. CSL Behring is not responsible for, and accepts no liability for, information contained in any third-party Web site.
Do you want to continue?